(Q41528506)

2 October 2017

1 reference

title

Anti-HIV ribozymes (English)

1 reference

2 October 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9219238

14 September 2024

anti-HIV agents

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9219238

14 September 2024

author name string

L. Q. Sun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9219238

14 September 2024

J. A. Ely

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9219238

14 September 2024

W. Gerlach

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9219238

14 September 2024

G. Symonds

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9219238

14 September 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9219238

14 September 2024

publication date

1 June 1997

1 reference

full work available at URL

2 October 2017

https://link.springer.com/content/pdf/10.1007/BF02740815.pdf

file format

Portable Document Format

1 reference

https://link.springer.com/article/10.1007/BF02740815/fulltext.html

14 September 2024

1 reference

http://link.springer.com/content/pdf/10.1007/BF02740815

14 September 2024

1 reference

14 September 2024

published in

Molecular Biotechnology

1 reference

2 October 2017

volume

7

1 reference

2 October 2017

issue

3

1 reference

2 October 2017

page(s)

241-251

1 reference

High-Level Viremia in Adults and Children Infected with Human Immunodeficiency Virus: Relation to Disease Stage and CD4+ Lymphocyte Levels

2 October 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02740815

Microbial isopenicillin N synthase genes: structure, function, diversity and evolution

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02740815

Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes

21 January 2018

1 reference

12 December 2020

Viral vector systems for gene therapy.

1 reference

12 December 2020

Specificity of hammerhead ribozyme cleavage

1 reference

12 December 2020

Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region.

1 reference

12 December 2020

Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1.

1 reference

12 December 2020

Adeno-associated virus vectors

1 reference

12 December 2020

Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.

1 reference

12 December 2020

Present Status and Future Prospects for HIV Therapies

1 reference

12 December 2020

Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems

1 reference

12 December 2020

Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.

1 reference

12 December 2020

Activity and cleavage site specificity of an anti-HIV-1 hairpin ribozyme in human T cells

1 reference

12 December 2020

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

1 reference

12 December 2020

Regulation of HIV and HTLV gene expression

1 reference

12 December 2020

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

12 December 2020

How does HIV cause AIDS?

1 reference

12 December 2020

Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1.

1 reference

12 December 2020

1 reference

12 December 2020

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1 reference

12 December 2020

The potential use of catalytic RNAs in therapy of HIV infection and other diseases

1 reference

12 December 2020

Ribozymes that cleave an RNA sequence from human immunodeficiency virus: the effect of flanking sequence on rate

1 reference

12 December 2020

Antitat gene therapy: a candidate for late-stage AIDS patients.

1 reference

12 December 2020

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

12 December 2020

Design and anti-HIV-1 activity of ribozymes that cleave HIV-1 LTR

1 reference

12 December 2020

Gene therapeutic agents: The use of ribozymes, antisense, and RNA decoys for HIV-1 infection

1 reference

12 December 2020

Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.

1 reference

12 December 2020

Gene therapy and immune restoration for HIV disease

1 reference

12 December 2020

Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines

1 reference

12 December 2020

Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro

1 reference

12 December 2020

Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme

1 reference

12 December 2020

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

1 reference

12 December 2020

Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.

1 reference

12 December 2020

RNA enzymes as tools for gene ablation

1 reference

12 December 2020

Ribozymes as potential anti-HIV-1 therapeutic agents.

1 reference

12 December 2020

Fusin--a place for HIV-1 and T4 cells to meet

1 reference

12 December 2020

HIV accessory proteins: leading roles for the supporting cast.

1 reference

12 December 2020

In vitro and in vivo characterization of a second functional hairpin ribozyme against HIV-1.

1 reference

12 December 2020

Therapy for human immunodeficiency virus infection -- what have we learned?

1 reference

12 December 2020

Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.

1 reference

12 December 2020

Lymphoid organs function as major reservoirs for human immunodeficiency virus

1 reference

12 December 2020

A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1

1 reference

12 December 2020

Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells

1 reference

12 December 2020

HIV as the cause of AIDS.

1 reference

12 December 2020

Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters

1 reference

12 December 2020

Viral latency in HIV disease.

1 reference

12 December 2020

Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1.

1 reference

12 December 2020

Characterization of several kinds of dimer minizyme: simultaneous cleavage at two sites in HIV-1 tat mRNA by dimer minizymes

1 reference

12 December 2020

Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates

1 reference

12 December 2020

Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector

1 reference

12 December 2020

Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.

1 reference

12 December 2020

Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells

1 reference

12 December 2020

Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro.

1 reference

12 December 2020

Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parametersin vitrobut causes loss of the inhibitory potential in living cells

1 reference

12 December 2020

Functional characterization of a U5 ribozyme: intracellular suppression of human immunodeficiency virus type 1 expression

1 reference

12 December 2020

RevM10-Mediated Inhibition of HIV-1 Replication in Chronically Infected T Cells

1 reference

12 December 2020

Intracellular susceptibility to ribozymes in a tethered substrate-ribozyme provirus model is not predicted by secondary structures of human immunodeficiency virus type 1 RNAs in vitro

1 reference

12 December 2020

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

12 December 2020

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

1 reference

12 December 2020

A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design

1 reference

12 December 2020

The enigma of HIV infection.

1 reference

12 December 2020

Inhibition of HIV-1 by a double transdominant fusion gene.

1 reference

12 December 2020

Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme.

1 reference

12 December 2020

Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites

1 reference

12 December 2020

Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector

1 reference

12 December 2020

A small catalytic oligoribonucleotide

1 reference

12 December 2020

HIV and other lentivirus-based vectors

1 reference

12 December 2020

Prevention of human immunodeficiency virus type 1 integrase expression in Escherichia coli by a ribozyme

1 reference

12 December 2020

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

Simple RNA enzymes with new and highly specific endoribonuclease activities

1 reference

12 December 2020

Improved retroviral vectors for gene transfer and expression

1 reference

12 December 2020

The chemistry of self-splicing RNA and RNA enzymes

1 reference

12 December 2020

Clinical treatment

18

1 reference

Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle

14 September 2024

22

1 reference

14 September 2024

69

7

980

A. D. Miller

1989

1 reference

14 September 2024

Identifiers

DOI

10.1007/BF02740815

1 reference

Dimensions Publication ID

2 October 2017

1047111493

0 references

1 reference